EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/02/2025
Back to search
Official data from USPTO
MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
07/09/2025
Trademark type
Combined
Nice classes
35
Filing date
04/13/2011
Registration date
01/15/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/18/2023
Last transaction
07/09/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
10/03/2010
First use in commerce
10/03/2010
Drawing code
3
Owner type
99
Owner location
Washington, DC
Examiner
TWOHIG,SHANNON MARIE
Law office
N20
Current location
TMO LAW OFFICE 120
Mark description
The mark consists of the words "MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM" stacked vertically above "ACCELERATING RESEARCH FOR A CURE" all to the right of a half-circle with seven radiating lines of dots that progressively diminish in size.
Holders and representatives
Holders
T. F. (pessoa física)
T. F. (pessoa física)
Melanoma Research Foundation Breakthrough Consortium, Inc.
Representatives
John Paul Oleksiuk Cooley LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of melanoma research; Promoting collaboration within the scientificresearch and medical communities to achieve advances in the field of melanoma research; Promoting collaboration within the scientificresearch and medical communities to develop and implement clinical trials for treatment in the field of melanoma
Publications
History of USPTO decisions and trademark events.
54 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/02/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/18/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/18/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/18/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/18/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
03/10/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/15/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/28/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/28/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/28/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/28/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/28/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/07/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/07/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/07/2019
E815
TEAS SECTION 8 & 15 RECEIVED
01/09/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/15/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
01/15/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/30/2012
PUBO
PUBLISHED FOR OPPOSITION
10/30/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/10/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/24/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/17/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/27/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/27/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/22/2012
ALIE
ASSIGNED TO LIE
08/16/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/15/2012
GNRT
NON-FINAL ACTION E-MAILED
02/15/2012
CNRT
NON-FINAL ACTION WRITTEN
02/15/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2012
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
07/24/2011
GPRA
PRIORITY ACTION E-MAILED
07/24/2011
CPRA
PRIORITY ACTION WRITTEN
07/24/2011
DOCK
ASSIGNED TO EXAMINER
07/19/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
04/19/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/18/2011
NWAP
NEW APPLICATION ENTERED
04/16/2011
Continuous trademark protection
Get notified about every new filing that threatens MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM ACCELERATING RESEARCH FOR A CURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.